Abstract
Renal tumors development depends on local angiogenesis. Contrast enhanced ultrasound exam is developing as an important instrument when it comes to small tumors diagnosis and their vascularization assessment and allows for a reliable, noninvasive evaluation, providing real-time information on lesion vascularity. The purpose of this study was to evaluate the diagnostic efficacy of cadence contrast pulse sequencing technology (CPS) in differentiating solid renal parenchymal lesions (SRPLs) with a maximum diameter of 5cm.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
